Scinovex
review Open AccessTop 1% cited

Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?

Pharmaceutical Research · 2008 · Vol. 26(1) · pp. 235–43
Paolo DecuzziRenata PasqualiniWadih ArapMauro Ferrari

Abstract

In cancer therapy and imaging, the systemic passive delivery of particulate systems has relied on the enhanced permeability and retention (EPR) effect: sufficiently small particles can cross the endothelial fenestrations and accumulate in the tumor parenchyma. The vast majority of man-made particulates exhibit a spherical shape as a result of surface energy minimization during their synthesis. The advent of phage display libraries, which are revealing the extraordinary molecular diversity of endothelial cells, and the development of processes for fabricating particles with shapes other than spherical are opening the path to new design solutions for systemically administered targeted particulates. In this paper, the role of particle geometry (i.e., size and shape) is discussed at the tissue and cellular scales. Emphasis is placed on how the synergistic effect of particle geometry and molecular targeting can enhance the specificity of delivery. The intravascular delivery process has been broken into three events: margination, firm adhesion and control of internalization. Predictions from mathematical models and observations from in-vitro experiments were used to show the relevance of particle geometry in systemic delivery. Rational design of particulate systems should consider, beside the physico-chemical properties of the surface coatings, geometrical features as size and shape. The integration of mathematical modeling with in-vitro and in-vivo testing provides the tools for establishing a rational design of nanoparticles.

Nanoparticle-Based Drug DeliveryGold and Silver Nanoparticles Synthesis and ApplicationsRNA Interference and Gene DeliveryNanotechnologyParticulatesRational designDrug deliveryIn vivoMaterials scienceBiophysicsChemistryBiology

MeSH terms

AnimalsCell AdhesionDelayed-Action PreparationsPharmaceutical PreparationsHumansInjections, IntravenousParticle SizeDrug DesignDrug Delivery SystemsPeptide LibraryParticulate Matter

Funding

  • U.S. Department of Defense
  • National Aeronautics and Space Administration
  • Texas Emerging Technology Fund
  • Marcus Foundation
Citations
601
FWCI
18.35
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
References
Cancer nanotechnology: opportunities and challenges
Nature reviews. Cancer · 2005 · 4,505 citations
Slow viscous motion of a sphere parallel to a plane wall—II Couette flow
Chemical Engineering Science · 1967 · 1,121 citations
Nanomedicine: current status and future prospects
The FASEB Journal · 2005 · 1,986 citations
THE VISCOSITY OF THE BLOOD IN NARROW CAPILLARY TUBES
American Journal of Physiology-Legacy Content · 1931 · 1,243 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? · Scinovex